CD86 and neoplasm: The DCs from the rapamycin-treated mice expressed higher levels of CD80, CD83, and CD86 in the peripheral blood; CD86 and MHC Class I in the peripheral lymph nodes; and CD40, CD80, CD86, MHC Class I, and MHC Class II in the spleens; and CD80 in the tumor than the dendritic cells from the control mice.